The thyroid gland manufactures hormones that regulate the body’s metabolism (the process of creating and using energy). There are several different disorders that can arise when the thyroid produces too much hormone (hyperthyroidism) or not enough (hypothyroidism). Four common thyroid disorders include Hashimoto’s disease, Graves’ disease, goiter, and thyroid nodules. The most serious form of hypothyroidism is called myxedema, which can lead to coma and even death. An underactive thyroid gland affects all organs and functions within the body, leading to both physical and emotional symptoms. Thyroid gland is prone to several distinct problems including underactive thyroid (hypothyroidism), overactive thyroid (hyperthyroidism), and thyroid nodules, autoimmune thyroiditis (Hashimoto’s thyroiditis), where hypothyroidism and hyperthyroidism are the most common disorders. Several therapeutic drugs are commercially available for these disorders. Hormone replacement drugs such as synthetic long acting thyroid hormones, levothyroxine and liothyronine are used for hypothyroidism, whereas hyperthyroidism is treated through therapeutics such as imidazole and propacil.
The global thyroid gland disorders treatment market report estimates the market size (Revenue USD million – 2014 to 2021) for key market segments based on the disorder treatment types (hyperthyroidism – imidazole, propacil, and hypothyroidism – levothyroxine, liothyronine), and forecasts growth trends (CAGR% – 2017 to 2021).
The global thyroid gland disorders treatment market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global thyroid gland disorders treatment market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global thyroid gland disorders treatment market and included in this report are AbbVie, Inc., Allergan plc, and Pfizer, Inc.